Coherus BioSciences Statistics

Total Valuation

CHRS has a market cap or net worth of $90.31 million. The enterprise value is $307.40 million.

Market Cap	90.31M
Enterprise Value	307.40M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CHRS has 115.93 million shares outstanding. The number of shares has increased by 12.48% in one year.

Current Share Class	115.93M
Shares Outstanding	115.93M
Shares Change (YoY)	+12.48%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	4.33%
Owned by Institutions (%)	54.41%
Float	110.89M

Valuation Ratios

The trailing PE ratio is 1.83.

PE Ratio	1.83
Forward PE	n/a
PS Ratio	0.33
Forward PS	0.82
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	180.62
P/OCF Ratio	180.62
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	614.81

Financial Position

The company has a current ratio of 1.22

Current Ratio	1.22
Quick Ratio	0.57
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	599.00
Interest Coverage	-3.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-9.10%
Return on Invested Capital (ROIC)	-20.04%
Return on Capital Employed (ROCE)	-71.21%
Revenue Per Employee	$1.19M
Profits Per Employee	-$574,285
Employee Count	228
Asset Turnover	0.48
Inventory Turnover	3.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.66% in the last 52 weeks. The beta is 1.01, so CHRS's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-57.66%
50-Day Moving Average	0.91
200-Day Moving Average	1.11
Relative Strength Index (RSI)	40.91
Average Volume (20 Days)	1,520,673

Short Selling Information

The latest short interest is 33.12 million, so 28.57% of the outstanding shares have been sold short.

Short Interest	33.12M
Short Previous Month	32.57M
Short % of Shares Out	28.57%
Short % of Float	29.86%
Short Ratio (days to cover)	18.14

Income Statement

In the last 12 months, CHRS had revenue of $272.25 million and -$130.94 million in losses. Loss per share was -$1.14.

Revenue	272.25M
Gross Profit	153.48M
Operating Income	-82.62M
Pretax Income	-29.72M
Net Income	-130.94M
EBITDA	-77.80M
EBIT	-82.62M
Loss Per Share	-$1.14

Full Income Statement

Balance Sheet

The company has $82.41 million in cash and $299.50 million in debt, giving a net cash position of -$217.09 million or -$1.87 per share.

Cash & Cash Equivalents	82.41M
Total Debt	299.50M
Net Cash	-217.09M
Net Cash Per Share	-$1.87
Equity (Book Value)	-183.47M
Book Value Per Share	-1.58
Working Capital	55.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	500,000
Capital Expenditures	n/a
Free Cash Flow	500,000
FCF Per Share	$0.00

Full Cash Flow Statement

Margins

Gross margin is 56.38%, with operating and profit margins of -30.35% and -48.09%.

Gross Margin	56.38%
Operating Margin	-30.35%
Pretax Margin	18.05%
Profit Margin	-48.09%
EBITDA Margin	-28.58%
EBIT Margin	-30.35%
FCF Margin	0.18%

Dividends & Yields

CHRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.48%
Shareholder Yield	-12.48%
Earnings Yield	-144.98%
FCF Yield	0.55%

Analyst Forecast

The average price target for CHRS is $4.68, which is 500.77% higher than the current price. The consensus rating is "Buy".

Price Target	$4.68
Price Target Difference	500.77%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	-1.66%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CHRS has an Altman Z-Score of -5.71 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.71
Piotroski F-Score	6